Rare DiseasesWeekly atacicept keeps kidney function steady in IgA nephropathy
In the ORIGIN 3 trial, people with IgA nephropathy on weekly atacicept lost almost no kidney function over two years, against about 5.6 eGFR units a year on placebo.
22 October 2026